Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hinge Health Inc. (HNGE : NYSE)

• Company Description    Hinge Health Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain and post-surgical rehabilitation. Hinge Health Inc. is based in San Francisco, California. Number of Employees: 1,437

• Price / Volume Information    Yesterday's Closing Price: $55.25 Daily Weekly Monthly 20 Day Moving Average: 1,706,838 shares Shares Outstanding: 77.38 (millions) Market Capitalization: $4,275.24 (millions) Beta: 52 Week High: $62.18 52 Week Low: $30.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 27.78% 21.53% 12 Week 26.52% 16.96% Year To Date 18.94% 9.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 455 MARKET STREET SUITE 700 - SAN FRANCISCO,CA 94105 USA ph: 415-726-2206 fax: - ir@hingehealth.com http://www.hingehealth.com

• General Corporate Information    Officers Daniel Perez - Chief Executive Officer and Director James Budge - Chief Financial Officer Kristina Leslie - Director Gabriel Mecklenburg - Director Elliott Robinson - Director Peer Information Hinge Health Inc. (HLIS) Hinge Health Inc. (AZTA) Hinge Health Inc. (APYI) Hinge Health Inc. (RNVA) Hinge Health Inc. (HMSY) Hinge Health Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 433313103 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 77.38 Most Recent Split Date: (:1) Beta: Market Capitalization: $4,275.24 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.21 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 45.85 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 38.28 Price/Cash Flow: - Price / Sales: 6.61 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 9.68% Sales Growth vs. Year Ago Period: 47.23% vs. Previous Quarter: 6.78% ROE 03/31/26 - -310.62 12/31/25 - -380.81 09/30/25 - - ROA 03/31/26 - -71.08 12/31/25 - -96.65 09/30/25 - - Current Ratio 03/31/26 - 1.30 12/31/25 - 1.47 09/30/25 - 1.85 Quick Ratio 03/31/26 - 1.27 12/31/25 - 1.43 09/30/25 - 1.81 Operating Margin 03/31/26 - -80.75 12/31/25 - -90.76 09/30/25 - - Net Margin 03/31/26 - -78.95 12/31/25 - -89.86 09/30/25 - - Pre-Tax Margin 03/31/26 - -78.82 12/31/25 - -89.69 09/30/25 - - Book Value 03/31/26 - 1.44 12/31/25 - 2.26 09/30/25 - 2.64 Inventory Turnover 03/31/26 - 8.62 12/31/25 - 11.02 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©